Resonetics

Resonetics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $100M

Overview

Resonetics is a privately held, Switzerland-headquartered company with principal operations in Nashua, New Hampshire, USA, founded in 1987. It operates as a specialized contract development and manufacturing organization (CDMO) and engineering services partner for the medical technology sector. The company's value proposition centers on accelerating time-to-market for clients through its vertically integrated Nitinol supply chain, rapid prototyping 'Lightspeed Labs,' and a broad portfolio of micro-manufacturing capabilities. With 18 global facilities and a focus on interventional, advanced surgery, diagnostics, and bioelectronics markets, Resonetics provides end-to-end support from concept to high-volume manufacturing.

Medical DevicesDrug Delivery

Technology Platform

Vertically integrated Nitinol (Melt to Market™) processing, micro-manufacturing (laser processing, microfluidic laminates, sensor integration), and a global network of rapid prototyping facilities (Lightspeed Labs).

Funding History

1
Total raised:$100M
Debt$100M

Opportunities

The growing trend of MedTech companies outsourcing complex manufacturing, coupled with demand for minimally invasive devices requiring Nitinol and micro-precision, presents a significant growth opportunity.
Recent acquisitions, like Resolution Medical, allow Resonetics to offer more integrated, end-to-end solutions and capture greater value per client program.

Risk Factors

Revenue is dependent on the R&D success and spending of client companies, creating cyclical exposure.
Intense competition in the CDMO space and the constant need for capital investment in advanced manufacturing technology pose threats to market position and margins.
Operational risks include maintaining quality at scale across global facilities and managing complex supply chains.

Competitive Landscape

Resonetics competes with large, diversified contract manufacturers (e.g., Flex, Jabil) and specialized medical device CDMOs (e.g., Integer Holdings, Teleflex OEM). Its primary differentiation is its deep, vertically integrated expertise in Nitinol and a strong focus on micro-manufacturing and rapid prototyping for the medical sector, offering a blend of material science and engineering services.